Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry - PubMed (original) (raw)
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry
Yoh Isobe et al. Gastric Cancer. 2011 Oct.
Abstract
The Japanese Gastric Cancer Association (JGCA) started a new nationwide gastric cancer registry in 2008. Approximately 50 data items, including surgical procedures, pathological diagnoses, and survival outcomes, for 12004 patients with primary gastric cancer treated in 2001 were collected retrospectively from 187 participating hospitals. Data were entered into the JGCA database according to the JGCA Classification of gastric carcinoma, 13th edition and the International Union Against Cancer (UICC) TNM Classification of malignant tumors, 5th edition by using an electronic data collecting system. Finally, data of 11261 patients with gastric resection were analyzed. The 5-year follow-up rate was 83.5%. The direct death rate was 0.6%. TNM 5-year survival rates (5YSRs)/JGCA 5YSRs were 91.8/91.9% for stage IA, 84.6/85.1% for stage IB, 70.5/73.1% for stage II, 46.6/51.0% for stage IIIA, 29.9/33.4% for stage IIIB, and 16.6/15.8% for stage IV. The proportion of patients more than 80 years old was 7.0%, and their 5YSR was 48.7%. Compared to the JGCA archived data, though the follow-up rate needs to be improved, these data suggest that the postoperative results of patients with primary gastric carcinoma have improved in those with advanced disease and in the aged population in Japan.
Figures
Fig. 1
Geographical distribution of the registered patients
Fig. 2
Hospital volumes in the 187 participating hospitals
Fig. 3
Kaplan–Meier survival for all 12004 patients with primary gastric cancer. 5YSR 5-year survival rate
Fig. 4
Kaplan–Meier survival for resected cases and unresected cases
Fig. 5
Kaplan–Meier survival of the resected cases stratified by sex
Fig. 6
Kaplan–Meier survival of the resected cases stratified by age
Fig. 7
Kaplan–Meier survival of the resected cases stratified by tumor location. W whole stomach, M middle third, L lower third, U upper third of stomach
Fig. 8
Kaplan–Meier survival of the resected cases stratified by macroscopic type
Fig. 9
Kaplan–Meier survival of the resected cases stratified by depth of tumor invasion. M mucosa or muscuralis mucosa, SM submucosa, MP muscularis propria, SS subserosal, SE serosa, SI adjacent structures
Fig. 10
Kaplan–Meier survival of the resected cases stratified by pT classification
Fig. 11
Kaplan–Meier survival of the resected cases stratified by lymph node metastasis
Fig. 12
Kaplan–Meier survival of the resected cases stratified by Japanese Gastric Cancer Association (JGCA) stage
Fig. 13
Kaplan–Meier survival of the resected cases stratified by TNM stage
Fig. 14
Kaplan–Meier survival of the resected cases stratified by curative potential of gastric resection. Resection A, no residual disease with high probability of cure satisfying all of the following conditions: T1 or T2; N0 treated by D1, 2, 3 resection or N1 treated by D2, 3 resection; M0, P0, H0, CY0, and proximal and distal margins >10 mm; Resection B, no residual disease but not fulfilling criteria for “Resection A”; Resection C, definite residual disease
Similar articles
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.
Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, Tsujitani S, Seto Y, Furukawa H, Oda I, Ono H, Tanabe S, Kaminishi M. Nashimoto A, et al. Gastric Cancer. 2013 Jan;16(1):1-27. doi: 10.1007/s10120-012-0163-4. Epub 2012 Jun 23. Gastric Cancer. 2013. PMID: 22729699 Free PMC article. - Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems.
Ikeguchi M, Murakami D, Kanaji S, Ohro S, Maeta Y, Yamaguchi K, Tatebe S, Kondo A, Tsujitani S, Kaibara N. Ikeguchi M, et al. ANZ J Surg. 2004 Oct;74(10):852-4. doi: 10.1111/j.1445-1433.2004.03188.x. ANZ J Surg. 2004. PMID: 15456431 - [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
Pan Y, Liang H, Xue Q, Zhang RP, Cui QH, Liu N, Wang BG. Pan Y, et al. Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):376-80. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953840 Chinese. - Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX. Lu J, et al. Surg Oncol. 2013 Sep;22(3):167-71. doi: 10.1016/j.suronc.2013.05.002. Epub 2013 Jun 18. Surg Oncol. 2013. PMID: 23787074 Review. - Gastric cancer staging with radiologic imaging modalities and UICC staging system.
Ahn HS, Kim SH, Kodera Y, Yang HK. Ahn HS, et al. Dig Surg. 2013;30(2):142-9. doi: 10.1159/000350881. Epub 2013 Jul 18. Dig Surg. 2013. PMID: 23867591 Review.
Cited by
- Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019.
Yu D, Ou Z, Zhang W, He H, Li Y, He W, Zhang M, Gao Y, Wu F, Chen Q. Yu D, et al. BMC Gastroenterol. 2022 Nov 28;22(1):493. doi: 10.1186/s12876-022-02567-5. BMC Gastroenterol. 2022. PMID: 36443660 Free PMC article. - Endoscopic submucosal dissection of a gastric mass.
Ebrahim A, Leeds SG, Clothier JS, Ward MA. Ebrahim A, et al. Proc (Bayl Univ Med Cent). 2019 Sep 23;32(4):629-630. doi: 10.1080/08998280.2019.1656006. eCollection 2019 Oct. Proc (Bayl Univ Med Cent). 2019. PMID: 31656446 Free PMC article. - Postoperative ratio of the maximum C-reactive protein level to the minimum peripheral lymphocyte count as a prognostic indicator for gastric cancer patients.
Kono Y, Saito H, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Yamamoto M, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Kono Y, et al. Surg Today. 2019 Mar;49(3):206-213. doi: 10.1007/s00595-018-1724-x. Epub 2018 Oct 13. Surg Today. 2019. PMID: 30317493 - Surgical outcomes and risk assessment for anastomotic complications after laparoscopic proximal gastrectomy with double-flap technique for upper-third gastric cancer.
Shoji Y, Nunobe S, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N. Shoji Y, et al. Gastric Cancer. 2019 Sep;22(5):1036-1043. doi: 10.1007/s10120-019-00940-0. Epub 2019 Mar 6. Gastric Cancer. 2019. PMID: 30838469
References
- Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:21–66. - PubMed
- Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Oda I, Kaminishi M, et al. The present state and problems of gastric cancer treatment from the view points of nationwide registry. Jpn J Cancer Clin. 2009;55:713.
- Isobe Y, Nashimoto A, Akazawa K, Hayashi K, Miyashiro I, Oda I, et al. Problems and future perspectives on the nationwide registry of gastric cancer. Gekachiryo. 2010;102:358–64.
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13 ed. Tokyo: Kanehara; 1999 (in Japanese). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical